CHOW TAI FOOK (01929) second quarter retail value decreased by 0.5% year-on-year.
CHOW TAI FOOK (01929) announced that for the three months ended September 30, 2026 (the second quarter), retail value decreased by 0.5% year-on-year. Among this, retail value in Mainland China decreased by 5.3%, while retail value in Hong Kong, Macau and other markets increased by 33.2%. During the quarter, same-store sales of directly operated stores in Mainland China (the Mainland) grew by 2.2%, while same-store sales of franchised stores declined by 2.9%. However, the Group's performance continued to outperform the jewelry retail market. Benefiting from a buoyant consumer sentiment and strong customer traffic, same-store sales in Hong Kong and Macau grew by 29.6% during the period, with Hong Kong up 24.0% and Macau up 47.3%.
CHOW TAI FOOK (01929) announces that for the three months ended September 30, 2026 (second quarter), retail value decreased by 0.5% year-on-year. Among this, retail value in Mainland China decreased by 5.3%, while retail value in Hong Kong, Macau and other markets increased by 33.2%. During the quarter, same-store sales of directly operated stores in Mainland China (the Mainland) grew by 2.2%, while same-store sales of franchised stores declined by 2.9%. However, the Group's performance continued to outperform the jewelry retail market. Benefiting from a buoyant consumer atmosphere and strong customer traffic, same-store sales in Hong Kong and Macau grew by 29.6% during the period, with Hong Kong rising 24.0% and Macau rising 47.3%.
During the quarter, the Group selectively opened 23 CHOW TAI FOOK jewelry retail points in the Mainland and closed 263 retail points, a net closure of 240 retail points. In Hong Kong, Macau and other markets, the Group net opened 1 CHOW TAI FOOK jewelry retail point during the quarter.
Related Articles

Shijiazhuang Yiling Pharmaceutical (002603.SZ) Subsidiary's Drug Clinical Trial Application for Jiangu Joint Granules Accepted

SINOPEC SEG (02386) repurchased 3.7845 million shares on October 22 for HK$19.4376 million.

7ROAD (00797) repurchased 60,000 shares on October 22 for HK$52,500.
Shijiazhuang Yiling Pharmaceutical (002603.SZ) Subsidiary's Drug Clinical Trial Application for Jiangu Joint Granules Accepted

SINOPEC SEG (02386) repurchased 3.7845 million shares on October 22 for HK$19.4376 million.

7ROAD (00797) repurchased 60,000 shares on October 22 for HK$52,500.






